Topics

MorphoSys: Schwerer Rückschlag

04:29 EDT 29 Oct 2019 | FinanzNachrichten

Kulmbach (www.aktiencheck.de) - MorphoSys-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des Biotech-Unternehmens...

Original Article: MorphoSys: Schwerer Rückschlag

NEXT ARTICLE

More From BioPortfolio on "MorphoSys: Schwerer Rückschlag"

Quick Search

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...